POLARINE TABLET

Pharmacy Only

Drug type: Therapeutic

ATC code: R06AB52

Dosage form: TABLET

Route of administration: ORAL

Active ingredient: PSEUDOEPHEDRINE HCl; DEXCHLORPHENIRAMINE MALEATE; DEXCHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HCL

Indications:

It is indicated in nasal and respiratory congestion, common cold, acute sinusitis, allergic rhinitis.

Contraindications:

This formula is contraindicated in patients exhibiting hypersensitivity to any of the components. Antihistamine are contraindicated in patients receiving monoamine oxidase inhibitors since these agents prolong and intensify the anticholinergic effects of anti-histamines. Antihistamines should not be used to treat lower respiratory tract symptoms. Sympathomimetic preparations are contraindicated in patients with severe hypertension, severe coronary artery disease and patients receiving MAO inhibitor therapy due to potentiation of the pressor effects of pseudoephedrine.

Dosage:

Tablet :Adults:One tablet three times daily.Syrup :Children 6 to 12 years:Half teaspoonful 6 hourly.Adults:One teaspoonful 6 hourly.

Registrant

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Approval Date

1994-01-18

Approval Number

SIN07612P

Manufacturer

SUNWARD PHARMACEUTICAL PRIVATE LIMITED SUNWARD PHARMACEUTICAL SDN BHD

Licence Holder

SUNWARD PHARMACEUTICAL PRIVATE LIMITED